Journal
FUTURE ONCOLOGY
Volume 13, Issue 12, Pages 1081-1089Publisher
FUTURE MEDICINE LTD
DOI: 10.2217/fon-2016-0479
Keywords
oligometastatic cancer; SBRT; stereotactic body radiation therapy; technical factors
Categories
Funding
- Elekta AB through the International Oligometastasis Consortium
- Elekta SA
- IBA
- Elekta AB
Ask authors/readers for more resources
Aim: Oligometastatic cancer is being increasingly managed with aggressive local therapy using stereotactic body radiation therapy (SBRT). However, few guidelines exist. We summarize the results of an international survey reviewing technical factors for extracranial SBRT for oligometastatic disease to guide safe management. Materials & methods: Seven highvolume centers contributed. Levels of agreement were categorized as strong (6-7 common responses), moderate (4-5), low (2-3) or no agreement. Results & conclusion: We present the results of a multi-national and multi-institutional survey of technical factors of SBRT for extracranial oligometastases. Key methods including target delineation, prescription doses, normal tissue constraints, imaging and set-up for safe implementation and practice of SBRT for oligometastasis have been identified. This manuscript will serve as a foundation for future clinical evaluations.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available